AIMC Topic: Drug Discovery

Clear Filters Showing 561 to 570 of 1550 articles

MD-GNN: A mechanism-data-driven graph neural network for molecular properties prediction and new material discovery.

Journal of molecular graphics & modelling
Molecular properties prediction and new material discovery are significant for the pharmaceutical industry, food, chemistry, and other fields. The popular methods are theoretical mechanism calculation and machine learning. There is a deviation betwee...

Protein model quality assessment using rotation-equivariant transformations on point clouds.

Proteins
Machine learning research concerning protein structure has seen a surge in popularity over the last years with promising advances for basic science and drug discovery. Working with macromolecular structure in a machine learning context requires an ad...

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease.

International journal of molecular sciences
Over the past three years, significant progress has been made in the development of novel promising drug candidates against COVID-19. However, SARS-CoV-2 mutations resulting in the emergence of new viral strains that can be resistant to the drugs use...

Explainability and white box in drug discovery.

Chemical biology & drug design
Recently, artificial intelligence (AI) techniques have been increasingly used to overcome the challenges in drug discovery. Although traditional AI techniques generally have high accuracy rates, there may be difficulties in explaining the decision pr...

Artificial Intelligence in Drug Toxicity Prediction: Recent Advances, Challenges, and Future Perspectives.

Journal of chemical information and modeling
Toxicity prediction is a critical step in the drug discovery process that helps identify and prioritize compounds with the greatest potential for safe and effective use in humans, while also reducing the risk of costly late-stage failures. It is esti...

Magicmol: a light-weighted pipeline for drug-like molecule evolution and quick chemical space exploration.

BMC bioinformatics
The flourishment of machine learning and deep learning methods has boosted the development of cheminformatics, especially regarding the application of drug discovery and new material exploration. Lower time and space expenses make it possible for sci...

DeepCancerMap: A versatile deep learning platform for target- and cell-based anticancer drug discovery.

European journal of medicinal chemistry
Discovering new anticancer drugs has been widely concerned and remains an open challenge. Target- and phenotypic-based experimental screening represent two mainstream anticancer drug discovery methods, which suffer from time-consuming, labor-intensiv...

DrugormerDTI: Drug Graphormer for drug-target interaction prediction.

Computers in biology and medicine
Drug-target interactions (DTI) prediction is a crucial task in drug discovery. Existing computational methods accelerate the drug discovery in this respect. However, most of them suffer from low feature representation ability, significantly affecting...

Novel Molecular Representations Using Neumann-Cayley Orthogonal Gated Recurrent Unit.

Journal of chemical information and modeling
Advances in deep neural networks (DNNs) have made a very powerful machine learning method available to researchers across many fields of study, including the biomedical and cheminformatics communities, where DNNs help to improve tasks such as protein...

Harmonizing across datasets to improve the transferability of drug combination prediction.

Communications biology
Combination treatment has multiple advantages over traditional monotherapy in clinics, thus becoming a target of interest for many high-throughput screening (HTS) studies, which enables the development of machine learning models predicting the respon...